Overview
Systemic Lupus Erythematosus is treated with 8 medications in our database, including prednisone, Dexamethasone Sodium Phosphate, Hydroxychloroquine sulfate, HYDROXYCHLOROQUINE SULFATE, Hydroxychloroquine Sulfate, and 3 more. 7 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pfizer, Merck, Sanofi, Hikma. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Systemic Lupus Erythematosus treatment below.
Also known as:
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsAssistance Publique - Hôpitaux de Paris
Hospital for Special Surgery, New York — EARLY_PHASE1
Assiut University
Federal University of Maranhao — NA
University of Sao Paulo — NA
Vanderbilt University Medical Center — PHASE2
Investigación en Hemofilia y Fisioterapia
EMD Serono Research & Development Institute, Inc. — PHASE3
The Children's Hospital of Zhejiang University School of Medicine — EARLY_PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
6 availableHYDROXYCHLOROQUINE SULFATE
* Patient Copay Amount: Not Publicly Available * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: Not Publicly Available * RxBIN, PCN, and Group numbers: Not Publi
Prednisone
* Patient Copay Amount: Not Publicly Available * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: Not Publicly Available * RxBIN, PCN, and Group numbers: Not Publi
Plaquenil
* Patient Copay Amount: Not Publicly Available * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: Must be a U.S. resident. * RxBIN, PCN, and Group numbers: Not Pub
DEXAMETHASONE SODIUM PHOSPHATE
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Dexamethasone 1.5 mg
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Dexamethasone Intensol, Dexamethasone
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
6 grantsPAN Foundation Systemic Lupus Erythematosus Fund
PAN Foundation
Applicants must be receiving treatment for systemic lupus erythematosus in the United States and possess health insurance that covers their specific medication. Additionally, household income must be at or below 500% of the Federal Poverty Level.
HealthWell Foundation Systemic Lupus Erythematosus Fund
HealthWell Foundation
Applicants must be receiving treatment for Systemic Lupus Erythematosus in the United States and have health insurance that covers their medication. Household income must generally be at or below 500% of the Federal Poverty Level, adjusted for family size and cost of living.
CreakyJoints Co-pay Cards and Financial Assistance
CreakyJoints
This directory provides information on various co-pay assistance cards, pharmaceutical programs, and nonprofit foundations for arthritis patients. Eligibility typically requires patients to have commercial or private insurance and not be covered by government programs such as Medicare or Medicaid.
SAPHNELO Co-pay Savings Program
Eligible patients must be adults with moderate to severe systemic lupus erythematosus (SLE) currently receiving other lupus medicines. The co-pay savings program is specifically for US consumers with commercial or private insurance.
Community
No community posts yet. Be the first to share your experience with Systemic lupus erythematosus.
Start the conversation →Latest news about Systemic lupus erythematosus
Disease timeline:
New recruiting trial: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Cutaneous Lupus Registry
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Cardiovascular Risk in Children With Chronic Conditions Study
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Rare AutoImmune SElf-management Programme Development
A new clinical trial is recruiting patients for Systemic lupus erythematosus
New recruiting trial: Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant
A new clinical trial is recruiting patients for Systemic lupus erythematosus
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Systemic lupus erythematosus
What is Systemic lupus erythematosus?
Systemic Lupus Erythematosus is treated with 8 medications in our database, including prednisone, Dexamethasone Sodium Phosphate, Hydroxychloroquine sulfate, HYDROXYCHLOROQUINE SULFATE, Hydroxychloroquine Sulfate, and 3 more. 7 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pfizer, Merck, Sanofi, Hikma. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Systemic Lupus Erythematosus treatment below.
How is Systemic lupus erythematosus inherited?
Systemic lupus erythematosus follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for Systemic lupus erythematosus?
Yes — 20 recruiting clinical trials are currently listed for Systemic lupus erythematosus on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Systemic lupus erythematosus?
25 specialists and care centers treating Systemic lupus erythematosus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Systemic lupus erythematosus?
6 FDA-approved treatments are currently tracked on UniteRare for Systemic lupus erythematosus. See the treatments and support programs sections for copay assistance, eligibility, and contact details.